Illumina: Scott Gottlieb
Illumina has appointed Scott Gottlieb to its board of directors. Gottlieb is currently a special partner at New Enterprises Associates and a resident fellow at the American Enterprise Institute. He previously served as the 23rd commissioner of the US Food and Drug Administration form 2017 to 2019. Prior to joining the US FDA as commissioner, Gottlieb was a clinical assistant professor at the New York University School of Medicine.
NeoGenomics: Kathryn McKenzie, William Bonello, Douglas Brown
NeoGenomics announced three leadership appointments: Kathryn McKenzie as CFO, William Bonello as president of the informatics division, and Douglas Brown as chief strategy and corporate development officer.
McKenzie was previously the VP of finance and chief accounting officer after joining NeoGenomics in 2017. She was also the assistant controller and director of financial reporting and treasury at Chico's FAS, and worked at Ernst and Young.
Bonello was previously the chief strategy and corporate development officer at NeoGenomics and will continue as director of investor relations, which he's been since 2018. Before joining NeoGenomics, he was a healthcare equity analyst at Craig-Hallum and senior VP for investor relations at Laboratory Corporation of America.
Brown is joining NeoGenomics from SVB Leerink, where he was senior managing director. He recently advised NeoGenomics on the acquisition of GenOptix and the oncology assets of Human Longevity.
DxTerity Diagnostics: Brett Swansiger
DxTerity Diagnostics has appointed Brett Swansiger as chief commercialization officer. Prior to DxTerity, Swansiger held multiple positions at MDxHealth, including VP of managed care and payor strategy. Before MDxHealth, he served as VP of managed care and Asia market access for Agendia. Prior to Agendia, Swansiger help multiple positions at Prometheus Laboratories.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.